论文部分内容阅读
目的:监测甲型H1N1流感病毒裂解疫苗接种后的不良反应,为临床应用提供资料。方法:对我院310名职工分批次注射甲型H1N1流感病毒裂解疫苗后发生不良反应的情况进行登记、总结,内容包括性别、年龄、全身药品不良反应(ADR)的临床表现、出现ADR的时间、症状描述、症状处理等,并与说明书中的ADR发生率进行比较。结果:全身ADR的发生率仅为9.35%,ADR的发生与性别、年龄无明显的差异性。监测结果与说明书中ADR发生率有不同。结论:甲型H1N1流感病毒裂解疫苗是安全的,无后遗症。
Objective: To monitor the adverse reactions after influenza A (H1N1) influenza virus vaccination and provide information for clinical application. Methods: 310 workers in our hospital in batches injected with influenza A H1N1 influenza virus vaccine after the occurrence of adverse reactions were registered and summarized, including gender, age, systemic adverse drug reaction (ADR) clinical manifestations of ADR Time, symptom description, symptom management, etc., and compared with the incidence of ADR in this manual. Results: The incidence of systemic ADR was only 9.35%. There was no significant difference in the occurrence of ADR between sex and age. Monitoring results and instructions in the incidence of ADR are different. Conclusion: Influenza A H1N1 influenza virus vaccine is safe, no sequelae.